Pearson plc
NYSE:PSOPublishing
-$0.11 today
- Market cap
- $10.27B
- Beta
- -0.04
- P/E (TTM)
- 21.4
- EPS (TTM)
- $0.53
- Dividend yield
- 2.24%
Volume 0.58M
Average 1.04M
PSO Stock-Based Compensation
Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.
Pearson plcNYSE: PSO
Stock-Based Compensation · Q4 FY2025 · quarter ended Dec 2025
Stock-based compensation outflow shrinks to £0
Q4 FY2025 stock-based compensation was £0, compared with £21M a year earlier. Over 3 fiscal years it compounded at +0.9% a year.
Context
- Stock-based compensation amounted to 1.1% of revenue in FY2025, down 0.1 pp from a year earlier.
- Stock-based compensation increased in 2 of the last 3 fiscal years.
Sources:Cash FlowText generated from reported figures; not investment advice.
Stock-Based Compensation history
GBP · from the cash flow
- Latest · FY2025
- 39M GBP
- Year-over-year change
- -11.4%
- 4-year CAGR
- +8.6%
| Period | Period end | Stock-Based Compensation | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 39M | -11.4% |
| FY2024 | 2024-12-31 | 44M | +10.0% |
| FY2023 | 2023-12-31 | 40M | +5.3% |
| FY2022 | 2022-12-31 | 38M | +35.7% |
| FY2021 | 2021-12-31 | 28M | — |
Stock-Based Compensation vs competitors
How PSO compares with its peers on the latest reported figures
- Peers report in different currencies, so stock-based compensation is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -11.4% is the 7th highest of 9, against a peer median of +0.7%.
- Stock-based compensation amounts to 1.1% of revenue for PSO, versus a peer median of 1.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $40.26M USD | +9.4% | +25.6% | 1.6% | |
| FY2025 | £39M GBP | -11.4% | +0.9% | 1.1% | |
MHMcGraw Hill, Inc. | LTM Jun 2026 | $37.61M USD | — | — | 1.8% |
| LTM Jul 2026 | $28.27M USD | +27.6% | -8.0% | 1.7% | |
| LTM Mar 2026 | $22.87M USD | -11.1% | +1.7% | 1.8% | |
| LTM Sep 2026 | $13.67M USD | -0.8% | +2.6% | 1.6% | |
| LTM Apr 2026 | $12M USD | -27.3% | -28.8% | 2.5% | |
| LTM Feb 2026 | $9.2M USD | +2.2% | +6.0% | 0.6% | |
| LTM Mar 2026 | $5.67M USD | +18.6% | -2.2% | 0.1% | |
| LTM Mar 2026 | $3.66M USD | -40.9% | — | 1.5% | |
| Peer median (excluding PSO) | — | +0.7% | +1.7% | 1.6% | |
Competitors are the stored peer set for PSO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 160M | 242M | 378M | 510M | 457M |
| Depreciation & Amortization | 408M | 572M | 543M | 526M | 558.49M |
| Deferred Income Tax | (280M) | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 28M | 38M | 40M | 44M | 39M |
| Change in Working Capital | 2M | 49M | (96M) | (53M) | (81.18M) |
| Accounts Receivables | (71M) | 33M | (24M) | 32M | (101.72M) |
| Inventory | 22M | (34M) | 9M | 15M | 4.89M |
| Accounts Payables | 37M | 0 | (20M) | 0 | 34.23M |
| Other Working Capital | 14M | 50M | (61M) | (100M) | (18.58M) |
| Other Non-Cash Items | 8M | (540M) | (340M) | (400M) | (298.43M) |
| Operating Cash Flow | 326M | 361M | 525M | 627M | 674.88M |
| Capital Expenditures | (176M) | (57M) | (126M) | (124M) | (28.36M) |
| Acquisitions (Net) | 18M | (228M) | (214M) | (46M) | (152.58M) |
| Purchases of Investments | (4M) | (12M) | (8M) | (7M) | (4.89M) |
| Sales of Investments | 48M | 0 | 7M | 0 | 0 |
| Other Investing Activities | 34M | 298M | (56M) | (45M) | 17.61M |
| Investing Cash Flow | (80M) | 13M | (301M) | (131M) | (270.93M) |
| Debt Repayment | (167M) | (264M) | (84M) | 344M | 43M |
| Common Stock Issued | 6M | 7M | 9M | 7M | 8.8M |
| Common Stock Repurchased | (16M) | (390M) | (221M) | (358M) | (414.71M) |
| Dividends Paid | (149M) | (156M) | (154M) | (156M) | (156.49M) |
| Other Financing Activities | (88M) | 6M | 9M | (78M) | (76.25M) |
| Financing Cash Flow | (414M) | (804M) | (450M) | (241M) | (595.65M) |
| Effect of Forex Changes | (8M) | 36M | (8M) | (21M) | 111.43M |
| Net Change in Cash | (176M) | (394M) | (234M) | 234M | (80.27M) |
| Free Cash Flow | 150M | 304M | 399M | 503M | 646.51M |
Pearson plc
NYSE:PSO
Intrinsic Alpha fair value
Locked
Current Price
$17.04
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.